|
COPS7A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.6956882826521E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.96249954859718E-10 |
| Normal-vs-Stage2 |
2.77260000003388E-06 |
| Normal-vs-Stage3 |
1.05659999638519E-08 |
| Normal-vs-Stage4 |
1.246380E-04 |
| Stage1-vs-Stage2 |
3.932400E-01 |
| Stage1-vs-Stage3 |
3.943800E-02 |
| Stage1-vs-Stage4 |
8.281000E-01 |
| Stage2-vs-Stage3 |
3.077600E-01 |
| Stage2-vs-Stage4 |
6.900200E-01 |
| Stage3-vs-Stage4 |
1.867180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.60245167030371E-12 |
| Normal-vs-AfricanAmerican |
3.000000E-04 |
| Normal-vs-Asian |
9.898100E-02 |
| Caucasian-vs-AfricanAmerican |
3.208400E-01 |
| Caucasian-vs-Asian |
4.540800E-01 |
| AfricanAmerican-vs-Asian |
6.747000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.86983761807369E-12 |
| Normal-vs-Female |
4.34379999969536E-07 |
| Male-vs-Female |
1.518490E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.402400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.51079999621828E-08 |
| Normal-vs-Age(61-80Yrs) |
6.80455691792758E-13 |
| Normal-vs-Age(81-100Yrs) |
1.641050E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.262200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.753800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.924200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.892350E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.070600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.878200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.164100E-03 |
| Normal-vs-Grade 2 |
1.97169947036002E-10 |
| Normal-vs-Grade 3 |
9.06209551843062E-11 |
| Normal-vs-Grade 4 |
1.434170E-04 |
| Grade 1-vs-Grade 2 |
6.048200E-01 |
| Grade 1-vs-Grade 3 |
1.415590E-01 |
| Grade 1-vs-Grade 4 |
5.210600E-01 |
| Grade 2-vs-Grade 3 |
1.958000E-01 |
| Grade 2-vs-Grade 4 |
9.431600E-01 |
| Grade 3-vs-Grade 4 |
4.631000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.44626541245907E-12 |
| Normal-vs-ccB subtype |
9.15380000021671E-07 |
| ccA subtype-vs-ccB subtype |
3.594000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.06540000050148E-08 |
| Normal-vs-N1 |
9.950600E-01 |
| N0-vs-N1 |
5.793500E-02 |
|
|
